C. A. Gordon

The Cui Bono of “Experiments” on the Brains of Animals

C. A. Gordon, 1886 .

Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2006, Advances in therapy.

Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2007, Medical hypotheses.

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2006, Advances in therapy.